| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |